Literature DB >> 10807536

Molecular analysis of alpha-thalassemia in Nepal: correlation with malaria endemicity.

Y Sakai1, S Kobayashi, H Shibata, H Furuumi, T Endo, S Fucharoen, S Hamano, G P Acharya, T Kawasaki, Y Fukumaki.   

Abstract

Thalassemia is a prevalent hereditary disorder characterized by impaired synthesis of globin chains. It has been suggested that the high frequency of thalassemia might reflect heterozygote advantage due to reduced susceptibility to malaria. In Nepal, malaria has often occurred in places below the altitude of 1,200m. We carried out a microepidemiological study on thalassemia in two neighboring populations in Nepal, the Danuwar and the Tamang. Settlements of the Danuwar are located below the limit of the malarial zone (1,200m in altitude), whereas those of the Tamang are found in malaria-free uplands. Three heterozygotes for hemoglobin E (HbE) were observed in the Danuwars. We detected one type (-alpha3.71) of alpha+-thalassemia that involves a deletion of 3.7kb, leading to a loss of one of two alpha-globin genes, in the Danuwars, at a high gene frequency of 63%, while the gene frequency in the Tamangs was only 5%. Analysis of the alpha-globin gene cluster revealed that four different haplotypes were associated with the type of alpha+-thalassemia in the Danuwars. Nucleotide sequences of the D-loop region in the mitochondrial DNA of the two populations indicated a similar nucleotide diversity in each population. The fixation index, FST, representing the degree of genetic differentiation estimated from mitochondrial DNA diversities (FST, 0.05), was smaller than that obtained from the gene frequencies of alpha-thalassemia (FST, 0.55). If we assume neutral molecular evolution in the D-loop region of mitochondrial DNA, these results suggest that the high frequency of alpha+-thalassemia may be due to biological adaptation to the malarial environment rather than to events such as a bottleneck.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807536     DOI: 10.1007/s100380050198

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  6 in total

1.  Evidence of positive selection on a class I ADH locus.

Authors:  Yi Han; Sheng Gu; Hiroki Oota; Michael V Osier; Andrew J Pakstis; William C Speed; Judith R Kidd; Kenneth K Kidd
Journal:  Am J Hum Genet       Date:  2007-01-30       Impact factor: 11.025

2.  Glucose-6-phosphate dehydrogenase deficiency in people living in malaria endemic districts of Nepal.

Authors:  Prakash Ghimire; Nihal Singh; Leonard Ortega; Komal Raj Rijal; Bipin Adhikari; Garib Das Thakur; Baburam Marasini
Journal:  Malar J       Date:  2017-05-23       Impact factor: 2.979

3.  Prevalence and correlates of anemia among adolescents in Nepal: Findings from a nationally representative cross-sectional survey.

Authors:  Binaya Chalise; Krishna Kumar Aryal; Ranju Kumari Mehta; Meghnath Dhimal; Femila Sapkota; Suresh Mehata; Khem Bahadur Karki; Donya Madjdian; George Patton; Susan Sawyer
Journal:  PLoS One       Date:  2018-12-14       Impact factor: 3.240

4.  Detection of Common Deletional of α-Thalassemia 3.7 Kb from Metropolitan Region of Manaus, Amazonas, Brazil.

Authors:  Fernanda Cozendey Anselmo; Abdou Gafar Soumanou; Cleidiane de Aguiar Ferreira; Flora Maia Viga Sobrinha; Ana Caroline Santos Castro; Rafael Oliveira Brito; Adolfo José da Mota; Marilda de Souza Gonçalves; José Pereira de Moura Neto
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-01-01       Impact factor: 2.576

5.  Nepalese populations show no association between the distribution of malaria and protective alleles.

Authors:  Cátia P Caetano; Thirsa Kraaijenbrink; Nirmal M Tuladhar; George L van Driem; Peter de Knijff; Chirs Tyler-Smith; Denise R Carvalho-Silva
Journal:  J Mol Genet Med       Date:  2006-11

6.  Recent Selection on a Class I ADH Locus Distinguishes Southwest Asian Populations Including Ashkenazi Jews.

Authors:  Sheng Gu; Hui Li; Andrew J Pakstis; William C Speed; David Gurwitz; Judith R Kidd; Kenneth K Kidd
Journal:  Genes (Basel)       Date:  2018-09-07       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.